MEDG Medgenics(Regs)

 

TIDMMEDG 
 
RNS Number : 7769B 
Medgenics Inc 
02 November 2009 
 

Medgenics, Inc. 
('Medgenics' or the 'Company') 
 
 
2 November 2009 
 
 
The Board of Medgenics announces that on 30 October 2009 Mr. Joel Kanter (a 
Director of the Company) informed the Company that on 30 October he acquired in 
the market 25,000 common shares of par value US$ 0.0001 each ("Common Shares") 
in the Company at a price of 9.2 pence per Common Share. 
 
 
The total interest in Shares of Mr. Kanter and his related parties following 
this purchase is 14,078,397 Common Shares representing approximately 11.5 % of 
the issued share capital of the Company (excluding his interest in warrants, 
options and convertible debentures as previously announced). 
 
 
For further information, contact: 
 
 
+----------------------------------------------------+---------------------------------------+ 
| Medgenics, Inc.                                    | Phone: +972 4 902 8900                | 
| Dr. Andrew L. Pearlman                             |                                       | 
|                                                    |                                       | 
+----------------------------------------------------+---------------------------------------+ 
| Grayling (Financial PR, UK)                        | Phone: +44 7900 053 536               | 
| Jonathan Shillington                               | jonathan.shillington@uk.grayling.com  | 
| Alistair Scott                                     |                                       | 
|                                                    |                                       | 
+----------------------------------------------------+---------------------------------------+ 
| Blomfield Corporate Finance Limited (Nominated     | Phone: +44 207 444 0800               | 
| Adviser)                                           |                                       | 
| James Pinner                                       |                                       | 
| Alan MacKenzie                                     |                                       | 
|                                                    |                                       | 
+----------------------------------------------------+---------------------------------------+ 
| SVS Securities plc (Broker)                        | Phone: +44 207 638 5600               | 
| Ian Callaway                                       |                                       | 
|                                                    |                                       | 
+----------------------------------------------------+---------------------------------------+ 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RDSEAAFAEFPNFFE 
 

Medgenics(Regs) (LSE:MEDG)
Historical Stock Chart
From May 2024 to Jun 2024

Medgenics(Regs) (LSE:MEDG)
Historical Stock Chart
From Jun 2023 to Jun 2024